Department of Human Parasitology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China.
Department of Infectious Diseases, Renmin Hospital, Hubei University of Medicine, Shiyan, China.
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.02387-17. Print 2018 Sep.
Antimalarial drug resistance developed in has become a problem for malaria control. Evaluation of drug resistance is the first step for effective malaria control. In this study, we investigated the gene mutations of using blood samples from returned Chinese migrant workers in order to identify drug resistance-associated molecular markers. These workers returned from Africa and Southeast Asia (SEA) during 2011 to 2016. Polymorphisms in , , and genes and the haplotype patterns of Pfcrt and Pfmdr1 were analyzed. The results showed the presence of four haplotypes of Pfcrt codons 72 to 76, including CVMNK (wild type), VMN and CV (mutation types), and CV M N K (mixed type), with 50.57%, 1.14%, 25.00%, and 23.30% prevalence, respectively. For Pfmdr1, N86 (22.28%) and Y184 (60.01%) were the main prevalent mutations (mutations are underlined). The prevalence of mutation at position 550, 561, 575, and 589 of K13-propeller were 1.09%, 0.54%, 0.54%, and 0.54%, respectively. These data suggested that Pfcrt, Pfmdr1, and K13-propeller polymorphisms are potential markers to assess drug resistance of in China, Africa, and SEA.
在 出现的抗疟药耐药性已成为疟疾控制的一个问题。耐药性评估是有效疟疾控制的第一步。在这项研究中,我们使用 2011 年至 2016 年期间从非洲和东南亚(SEA)返回的中国农民工的血液样本,调查了 的基因突变,以确定与耐药性相关的分子标记。分析了 、 、 和 基因的多态性以及 Pfcrt 和 Pfmdr1 的单倍型模式。结果显示 Pfcrt 密码子 72 到 76 存在四种单倍型,包括 CVMNK(野生型)、VMN 和 CV(突变型)以及 CV M N K(混合型),分别占 50.57%、1.14%、25.00%和 23.30%。对于 Pfmdr1,N86(22.28%)和 Y184(60.01%)是主要的流行突变(突变用下划线表示)。K13-推进器 550、561、575 和 589 位置的突变率分别为 1.09%、0.54%、0.54%和 0.54%。这些数据表明,Pfcrt、Pfmdr1 和 K13-推进器的多态性是评估中国、非洲和 SEA 疟原虫耐药性的潜在标志物。